Financials Aurora Spine Corporation
Equities
ASG
CA05206X1087
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.265 CAD | 0.00% | +6.00% | -33.75% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 12.47 | 10.01 | 17.4 | 18.21 | 22.39 | 23.19 |
Enterprise Value (EV) 1 | 13.63 | 12.1 | 18.16 | 17.58 | 24.94 | 26.07 |
P/E ratio | -170 x | -7.98 x | -73.9 x | -6.79 x | -14.9 x | -12.7 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.44 x | 0.9 x | 2.01 x | 1.73 x | 1.51 x | 1.6 x |
EV / Revenue | 1.57 x | 1.09 x | 2.1 x | 1.67 x | 1.68 x | 1.8 x |
EV / EBITDA | 15.6 x | -15 x | -26.5 x | -8.56 x | -33.6 x | -34.2 x |
EV / FCF | 675 x | 302 x | -18.3 x | -7.17 x | -11.9 x | -27.1 x |
FCF Yield | 0.15% | 0.33% | -5.46% | -14% | -8.4% | -3.7% |
Price to Book | 4.31 x | 5.66 x | 5.31 x | 3.27 x | 5.21 x | 4.41 x |
Nbr of stocks (in thousands) | 45,434 | 46,478 | 55,410 | 66,731 | 66,731 | 76,867 |
Reference price 2 | 0.2746 | 0.2154 | 0.3140 | 0.2729 | 0.3356 | 0.3017 |
Announcement Date | 19-04-26 | 20-06-04 | 21-04-30 | 22-04-29 | 23-04-28 | 24-04-30 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 8.682 | 11.15 | 8.646 | 10.54 | 14.88 | 14.52 |
EBITDA 1 | 0.872 | -0.8052 | -0.6862 | -2.054 | -0.7412 | -0.763 |
EBIT 1 | 0.0914 | -1.079 | -1.163 | -2.55 | -1.343 | -1.495 |
Operating Margin | 1.05% | -9.68% | -13.46% | -24.19% | -9.03% | -10.3% |
Earnings before Tax (EBT) 1 | -0.0682 | -1.254 | -0.2321 | -2.359 | -1.501 | -1.681 |
Net income 1 | -0.0682 | -1.254 | -0.2321 | -2.359 | -1.501 | -1.681 |
Net margin | -0.79% | -11.25% | -2.68% | -22.37% | -10.09% | -11.57% |
EPS 2 | -0.001617 | -0.0270 | -0.004247 | -0.0402 | -0.0225 | -0.0238 |
Free Cash Flow 1 | 0.0202 | 0.0401 | -0.9918 | -2.453 | -2.096 | -0.9637 |
FCF margin | 0.23% | 0.36% | -11.47% | -23.26% | -14.09% | -6.64% |
FCF Conversion (EBITDA) | 2.32% | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-04-26 | 20-06-04 | 21-04-30 | 22-04-29 | 23-04-28 | 24-04-30 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.16 | 2.09 | 0.76 | - | 2.55 | 2.88 |
Net Cash position 1 | - | - | - | 0.63 | - | - |
Leverage (Debt/EBITDA) | 1.33 x | -2.599 x | -1.103 x | - | -3.437 x | -3.773 x |
Free Cash Flow 1 | 0.02 | 0.04 | -0.99 | -2.45 | -2.1 | -0.96 |
ROE (net income / shareholders' equity) | -2.96% | -53.1% | -9.19% | -53.3% | -30.4% | -35% |
ROA (Net income/ Total Assets) | 0.94% | -9.98% | -10.5% | -18% | -8.12% | -8.46% |
Assets 1 | -7.239 | 12.56 | 2.207 | 13.11 | 18.5 | 19.88 |
Book Value Per Share 2 | 0.0600 | 0.0400 | 0.0600 | 0.0800 | 0.0600 | 0.0700 |
Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0300 | 0.0500 | 0.0100 | 0.0100 |
Capex 1 | 0.29 | 0.29 | 0.51 | 0.72 | 0.77 | 0.48 |
Capex / Sales | 3.37% | 2.57% | 5.9% | 6.83% | 5.18% | 3.3% |
Announcement Date | 19-04-26 | 20-06-04 | 21-04-30 | 22-04-29 | 23-04-28 | 24-04-30 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-33.75% | 15.02M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- ASG Stock
- Financials Aurora Spine Corporation